Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

5.35
Delayed Data
As of Feb 24
 +0.09 / +1.71%
Today’s Change
4.86
Today|||52-Week Range
8.06
+4.90%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close5.26
Today’s open5.35
Day’s range5.35 - 5.35
Volume335
Average volume (3 months)11,495
Market cap$136.3M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...0.000.00%
--Wang On Group Ltd0.000.00%
GNCAGenocea Biosciences ...-0.09-1.92%
QUREUniqure NV-0.10-1.71%
Data as of 4:00pm ET, 02/24/2017

Financials

Last reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Tel Aviv

Forecasts


Search for Jobs